Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hypertension, Pregnancy-Induced | 9 | 2020 | 208 | 3.12 | Why? |
| Pre-Eclampsia | 15 | 2018 | 599 | 1.89 | Why? |
| Prenatal Care | 6 | 2020 | 1314 | 0.77 | Why? |
| Maternal-Child Health Services | 1 | 2020 | 124 | 0.75 | Why? |
| Pregnancy | 45 | 2021 | 23879 | 0.73 | Why? |
| Maternal Health Services | 8 | 2021 | 808 | 0.70 | Why? |
| Birth Weight | 2 | 2018 | 250 | 0.67 | Why? |
| Reagent Strips | 1 | 2017 | 129 | 0.64 | Why? |
| Pregnancy Complications, Cardiovascular | 4 | 2018 | 231 | 0.57 | Why? |
| Antihypertensive Agents | 6 | 2018 | 1962 | 0.57 | Why? |
| Pregnancy Outcome | 9 | 2021 | 3803 | 0.57 | Why? |
| Proteinuria | 2 | 2018 | 474 | 0.54 | Why? |
| Blood Pressure Determination | 4 | 2018 | 450 | 0.54 | Why? |
| Prenatal Exposure Delayed Effects | 1 | 2018 | 319 | 0.54 | Why? |
| Child Development | 1 | 2018 | 352 | 0.53 | Why? |
| Placenta Growth Factor | 3 | 2017 | 93 | 0.50 | Why? |
| Stillbirth | 6 | 2021 | 544 | 0.44 | Why? |
| Blood Pressure Monitoring, Ambulatory | 3 | 2018 | 341 | 0.42 | Why? |
| Premature Birth | 3 | 2021 | 2151 | 0.41 | Why? |
| Pregnancy Complications, Infectious | 6 | 2021 | 11559 | 0.41 | Why? |
| Blood Pressure | 4 | 2018 | 2198 | 0.41 | Why? |
| Maternal Health | 3 | 2017 | 331 | 0.35 | Why? |
| Maternal Mortality | 6 | 2018 | 461 | 0.29 | Why? |
| Infant, Newborn | 12 | 2021 | 23105 | 0.25 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.25 | Why? |
| Infant Mortality | 3 | 2020 | 268 | 0.25 | Why? |
| Preventive Health Services | 2 | 2018 | 501 | 0.23 | Why? |
| Gestational Age | 5 | 2018 | 1488 | 0.23 | Why? |
| Hypertension | 6 | 2018 | 8895 | 0.23 | Why? |
| Female | 47 | 2021 | 380317 | 0.20 | Why? |
| Infant Health | 2 | 2020 | 160 | 0.19 | Why? |
| Practice Guidelines as Topic | 4 | 2020 | 15421 | 0.19 | Why? |
| Eclampsia | 1 | 2018 | 38 | 0.18 | Why? |
| Magnesium Sulfate | 1 | 2018 | 52 | 0.18 | Why? |
| Autoanalysis | 1 | 2017 | 2 | 0.18 | Why? |
| Risk Assessment | 9 | 2020 | 25439 | 0.17 | Why? |
| Pregnancy, High-Risk | 1 | 2018 | 128 | 0.17 | Why? |
| Protein C | 1 | 2018 | 141 | 0.17 | Why? |
| Pregnant Women | 2 | 2021 | 2535 | 0.17 | Why? |
| Early Medical Intervention | 2 | 2018 | 487 | 0.17 | Why? |
| Evidence-Based Practice | 3 | 2018 | 693 | 0.16 | Why? |
| Mozambique | 4 | 2017 | 205 | 0.16 | Why? |
| Hospitals, Private | 1 | 2018 | 198 | 0.16 | Why? |
| United Kingdom | 7 | 2021 | 18046 | 0.16 | Why? |
| Hypothalamo-Hypophyseal System | 1 | 2018 | 187 | 0.16 | Why? |
| Nepal | 1 | 2020 | 1004 | 0.15 | Why? |
| Pregnancy Complications | 2 | 2018 | 1388 | 0.15 | Why? |
| Technology Assessment, Biomedical | 1 | 2017 | 106 | 0.15 | Why? |
| Fetal Membranes, Premature Rupture | 1 | 2016 | 122 | 0.15 | Why? |
| Community Health Workers | 2 | 2018 | 468 | 0.15 | Why? |
| Puerperal Disorders | 1 | 2017 | 151 | 0.15 | Why? |
| False Positive Reactions | 2 | 2017 | 1338 | 0.14 | Why? |
| Diuretics | 1 | 2017 | 326 | 0.14 | Why? |
| Humans | 47 | 2021 | 930598 | 0.12 | Why? |
| Anticonvulsants | 1 | 2018 | 634 | 0.12 | Why? |
| Emergency Treatment | 1 | 2018 | 719 | 0.12 | Why? |
| Hospitals, Public | 1 | 2018 | 774 | 0.12 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.11 | Why? |
| Vaccination Coverage | 1 | 2021 | 1249 | 0.11 | Why? |
| Community Health Services | 2 | 2018 | 1000 | 0.11 | Why? |
| Weather | 1 | 2017 | 581 | 0.11 | Why? |
| Transportation | 1 | 2017 | 691 | 0.10 | Why? |
| Decision Support Techniques | 1 | 2018 | 903 | 0.10 | Why? |
| Organizational Innovation | 1 | 2020 | 2468 | 0.10 | Why? |
| Biological Specimen Banks | 1 | 2018 | 1142 | 0.10 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.09 | Why? |
| Postpartum Hemorrhage | 2 | 2021 | 144 | 0.09 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.09 | Why? |
| Prospective Studies | 5 | 2020 | 43301 | 0.09 | Why? |
| Health Resources | 2 | 2018 | 2592 | 0.09 | Why? |
| Income | 1 | 2017 | 1564 | 0.08 | Why? |
| Fibrinolytic Agents | 1 | 2018 | 1702 | 0.08 | Why? |
| Area Under Curve | 3 | 2018 | 2564 | 0.08 | Why? |
| Patient Acceptance of Health Care | 3 | 2020 | 5002 | 0.08 | Why? |
| ROC Curve | 4 | 2018 | 6024 | 0.07 | Why? |
| Canada | 4 | 2018 | 6018 | 0.07 | Why? |
| Prognosis | 5 | 2018 | 32490 | 0.07 | Why? |
| Postnatal Care | 2 | 2018 | 346 | 0.07 | Why? |
| Women's Health | 2 | 2020 | 444 | 0.07 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.07 | Why? |
| Focus Groups | 2 | 2018 | 811 | 0.07 | Why? |
| Logistic Models | 4 | 2021 | 9089 | 0.06 | Why? |
| Feasibility Studies | 3 | 2018 | 3467 | 0.06 | Why? |
| Adult | 20 | 2021 | 244371 | 0.06 | Why? |
| Intensive Care Units, Neonatal | 2 | 2021 | 749 | 0.06 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2020 | 5164 | 0.06 | Why? |
| Primary Health Care | 2 | 2018 | 4839 | 0.06 | Why? |
| Biomarkers | 4 | 2018 | 23361 | 0.06 | Why? |
| Decision Making | 1 | 2016 | 3132 | 0.06 | Why? |
| Qualitative Research | 3 | 2021 | 4337 | 0.06 | Why? |
| Referral and Consultation | 1 | 2018 | 4816 | 0.06 | Why? |
| Emergency Medical Services | 1 | 2018 | 3557 | 0.06 | Why? |
| Morbidity | 2 | 2018 | 1426 | 0.05 | Why? |
| Cesarean Section | 2 | 2021 | 2089 | 0.05 | Why? |
| Infant, Small for Gestational Age | 1 | 2021 | 151 | 0.05 | Why? |
| Infant | 3 | 2018 | 30274 | 0.05 | Why? |
| Obstetric Labor Complications | 1 | 2021 | 119 | 0.05 | Why? |
| Caribbean Region | 1 | 2021 | 349 | 0.05 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.05 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.05 | Why? |
| Congenital Abnormalities | 1 | 2021 | 170 | 0.05 | Why? |
| Health Care Surveys | 2 | 2020 | 2942 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Health Facilities | 2 | 2018 | 1230 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Pakistan | 2 | 2017 | 2302 | 0.05 | Why? |
| Parity | 1 | 1999 | 122 | 0.05 | Why? |
| Infusions, Parenteral | 1 | 2018 | 41 | 0.05 | Why? |
| Risk Factors | 8 | 2020 | 71621 | 0.05 | Why? |
| Early Diagnosis | 2 | 2017 | 2443 | 0.05 | Why? |
| HELLP Syndrome | 1 | 2018 | 52 | 0.04 | Why? |
| Pregnancy Trimesters | 1 | 2018 | 90 | 0.04 | Why? |
| Young Adult | 9 | 2021 | 93724 | 0.04 | Why? |
| Glasgow Coma Scale | 1 | 2018 | 249 | 0.04 | Why? |
| Peripartum Period | 1 | 2018 | 89 | 0.04 | Why? |
| Fiji | 1 | 2017 | 31 | 0.04 | Why? |
| Haiti | 1 | 2017 | 175 | 0.04 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.04 | Why? |
| Amnion | 1 | 2016 | 55 | 0.04 | Why? |
| Parturition | 1 | 2021 | 514 | 0.04 | Why? |
| Reference Standards | 1 | 2021 | 1163 | 0.04 | Why? |
| Sodium | 1 | 2018 | 309 | 0.04 | Why? |
| British Columbia | 1 | 2018 | 512 | 0.04 | Why? |
| Child | 3 | 2020 | 70012 | 0.04 | Why? |
| India | 3 | 2018 | 11875 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Africa South of the Sahara | 1 | 2020 | 1335 | 0.04 | Why? |
| Evaluation Studies as Topic | 1 | 2017 | 391 | 0.04 | Why? |
| Bilirubin | 1 | 2018 | 503 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.04 | Why? |
| Urban Health | 1 | 2017 | 382 | 0.03 | Why? |
| Rural Population | 2 | 2017 | 2408 | 0.03 | Why? |
| Health Promotion | 2 | 2018 | 2020 | 0.03 | Why? |
| Perinatal Death | 1 | 2016 | 372 | 0.03 | Why? |
| Medication Therapy Management | 1 | 2017 | 312 | 0.03 | Why? |
| HIV Infections | 1 | 1999 | 11620 | 0.03 | Why? |
| Uganda | 1 | 2017 | 1057 | 0.03 | Why? |
| Health Services Accessibility | 1 | 2017 | 10697 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.03 | Why? |
| Propensity Score | 1 | 2021 | 2690 | 0.03 | Why? |
| Research Design | 2 | 2020 | 5830 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Appointments and Schedules | 1 | 2020 | 1204 | 0.03 | Why? |
| Walking | 1 | 2017 | 442 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2017 | 9537 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Survival Rate | 2 | 2017 | 9206 | 0.03 | Why? |
| Creatinine | 1 | 2018 | 1443 | 0.03 | Why? |
| Interviews as Topic | 1 | 2021 | 1952 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2018 | 15909 | 0.03 | Why? |
| Down-Regulation | 1 | 2017 | 1416 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Telemedicine | 1 | 2021 | 25032 | 0.02 | Why? |
| Nigeria | 1 | 2017 | 2292 | 0.02 | Why? |
| Social Determinants of Health | 1 | 2021 | 1757 | 0.02 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2021 | 6543 | 0.02 | Why? |
| Netherlands | 1 | 2018 | 3533 | 0.02 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.02 | Why? |
| Intensive Care Units | 3 | 2021 | 29594 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2018 | 3786 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| State Medicine | 1 | 2020 | 2847 | 0.02 | Why? |
| South Africa | 1 | 2017 | 3326 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Remote Consultation | 1 | 2020 | 2396 | 0.02 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.02 | Why? |
| Mobile Applications | 1 | 2021 | 3032 | 0.02 | Why? |
| Odds Ratio | 1 | 2016 | 5861 | 0.02 | Why? |
| Fever | 1 | 2021 | 7795 | 0.02 | Why? |
| Male | 6 | 2018 | 367725 | 0.01 | Why? |
| Developing Countries | 1 | 2018 | 4283 | 0.01 | Why? |
| Retrospective Studies | 3 | 2018 | 105322 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Brazil | 1 | 2017 | 12582 | 0.01 | Why? |
| Mass Screening | 1 | 1999 | 8005 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2016 | 8495 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Stress, Psychological | 1 | 1999 | 10231 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Middle Aged | 1 | 2017 | 270681 | 0.00 | Why? |
Magee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(193)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(67)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_